This SEC Form 3 filing documents a power of attorney granted by Christina Shafer, Chief Commercial Officer of Neurogene Inc. (NGNE), to several individuals including Rachel McMinn, Christine Mikail, Donna M. Cochener, Ryan A. Murr, and Branden C. Berns. The power of attorney authorizes these individuals to prepare and ...

Xuebo Zeng, a director at CASI Pharmaceuticals, Inc., reported the acquisition of derivative securities on March 18, 2026. The filing details three option grants, all of which are fully vested and exercisable. The first option, with an exercise price of $1.93, gives the right to buy 11,231 Ordinary Shares and expires o...

Knight Jeff E., Chief Dev & Operating Officer of ALX Oncology Holdings Inc., has executed a Power of Attorney document. This document appoints Jason Lettmann, Harish Shantharam, and Shelly Wong as attorneys-in-fact. They are authorized to complete and execute SEC filings, including Forms 3, 4, and 5, and any amendments...

This filing reports insider ownership information for Bethany Sensenig, a director at Alpha Cognition Inc. (ACOG). The report indicates that Ms. Sensenig has no securities owned as of the period of report, April 15, 2026. The filing is made in accordance with SEC regulations for reporting changes in beneficial ownershi...